Literature DB >> 1335366

FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains.

L Li1, J Zhou, G James, R Heller-Harrison, M P Czech, E N Olson.   

Abstract

Myogenin belongs to a family of myogenic helix-loop-helix (HLH) proteins that activate muscle transcription through binding to a conserved DNA sequence associated with numerous muscle-specific genes. Fibroblast growth factor (FGF) inhibits myogenesis by inactivating myogenic HLH proteins. We show that activated protein kinase C (PKC) can substitute for FGF and inhibit transcriptional activity of myogenic HLH proteins. In transfected cells, FGF induces phosphorylation of a conserved site in the DNA-binding domain of myogenin. This site is phosphorylated by PKC in vivo and in vitro and mediates repression of the myogenic program through a loss in DNA binding activity. A myogenin mutant lacking the PKC phosphorylation site is not repressed by FGF, confirming this site as a molecular target for FGF-dependent repression of muscle transcription. These results establish a direct link between the signal transduction pathways that inhibit myogenesis and the transcription factors directly activating muscle-specific genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335366     DOI: 10.1016/s0092-8674(05)80066-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  82 in total

1.  cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.

Authors:  M Kitzmann; M Vandromme; V Schaeffer; G Carnac; J C Labbé; N Lamb; A Fernandez
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

Authors:  U Delling; J Tureckova; H W Lim; L J De Windt; P Rotwein; J D Molkentin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation.

Authors:  Jean-Bernard Lazaro; Peter J Bailey; Andrew B Lassar
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

Review 4.  Combinatorial transcriptional interaction within the cardiac neural crest: a pair of HANDs in heart formation.

Authors:  Anthony B Firulli; Simon J Conway
Journal:  Birth Defects Res C Embryo Today       Date:  2004-06

Review 5.  Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players.

Authors:  Clara Sciorati; Emilio Clementi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

6.  Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation.

Authors:  S E Johnson; X Wang; S Hardy; E J Taparowsky; S F Konieczny
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

7.  Identification of novel MyoD gene targets in proliferating myogenic stem cells.

Authors:  Jeffrey C Wyzykowski; Therry I Winata; Natalia Mitin; Elizabeth J Taparowsky; Stephen F Konieczny
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type.

Authors:  E R Chin; E N Olson; J A Richardson; Q Yang; C Humphries; J M Shelton; H Wu; W Zhu; R Bassel-Duby; R S Williams
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

9.  Inhibition of mammalian muscle differentiation by regeneration blastema extract of Sternopygus macrurus.

Authors:  Hyun-Jung Kim; Eric Archer; Norma Escobedo; Stephen J Tapscott; Graciela A Unguez
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

10.  The kinase inhibitor iso-H7 stimulates rat satellite cell differentiation through a non-protein kinase C pathway by increasing myogenin expression level.

Authors:  C Lagord; M P Leibovitch; G Carpentier; S A Leibovitch; I Martelly
Journal:  Cell Biol Toxicol       Date:  1996-06       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.